New hope for breast cancer with limited spread: targeted therapy trial launches

This study is for people with breast cancer that has spread to only a few spots in the body (oligometastasis). It tests whether adding focused treatments like radiation or surgery to the cancer spots, along with standard drug therapy, can help people live longer. About 340 participants will receive 12 weeks of standard drugs first, then either continue drugs alone or add targeted treatment to the spots.